FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Seppo Saarikoski

Research Profile

Geographic Areas

Finland

Procedures

Physiology

Disorders

Concepts & Ideas

Chemicals & Drugs

Anatomy

Activities & Behaviors

Smoking

Co-author Network

Publications

TOP 3
Marjo Tuppurainen; Kirsi Härmä; Marja Komulainen; Vesa Kiviniemi; Heikki Kröger; Risto Honkanen; Esko Alhava; Jukka Jurvelin; Seppo Saarikoski
Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: a 5-year follow-up.
Kati Pentti; Marjo Tuppurainen; Risto Honkanen; Lorenzo Sandini; Heikki Kröger; Esko Alhava; Seppo Saarikoski
Hormone therapy protects from diabetes: the Kuopio osteoporosis risk factor and prevention study.
Kati Pentti; Marjo T Tuppurainen; Risto Honkanen; Lorenzo Sandini; Heikki Kröger; Esko Alhava; Seppo Saarikoski
Use of calcium supplements and the risk of coronary heart disease in 52-62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Seppo Saarikoski (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Marjo Tuppurainen; Kirsi Härmä; Marja Komulainen; Vesa Kiviniemi; Heikki Kröger; Risto Honkanen; Esko Alhava; Jukka Jurvelin; Seppo Saarikoski
Effects of continuous combined hormone replacement therapy and clodronate on bone mineral density in osteoporotic postmenopausal women: a 5-year follow-up.
Maturitas 2010;66(4):423-30.
2009: Kati Pentti; Marjo Tuppurainen; Risto Honkanen; Lorenzo Sandini; Heikki Kröger; Esko Alhava; Seppo Saarikoski
Hormone therapy protects from diabetes: the Kuopio osteoporosis risk factor and prevention study.
European journal of endocrinology / European Federation of Endocrine Societies 2009;160(6):979-83.
2009: Kati Pentti; Marjo T Tuppurainen; Risto Honkanen; Lorenzo Sandini; Heikki Kröger; Esko Alhava; Seppo Saarikoski
Use of calcium supplements and the risk of coronary heart disease in 52-62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study.
Maturitas 2009;63(1):73-8.
2009: Aline Simen-Kapeu; Guy La Ruche; Vesa Kataja; Merja Yliskoski; Christine Bergeron; Apollinaire Horo; Kari Syrjänen; Seppo Saarikoski; Matti Lehtinen; François Dabis; Annie J Sasco
Tobacco smoking and chewing as risk factors for multiple human papillomavirus infections and cervical squamous intraepithelial lesions in two countries (Côte d'Ivoire and Finland) with different tobacco exposure.
Cancer causes & control : CCC 2009;20(2):163-70.
2008: Marja Komulainen; Heikki Kröger; Marjo Tuppurainen; Anna-Mari Heikkinen; Esko Alhava; Risto Honkanen; Seppo Saarikoski
HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial.
Maturitas 2008;61(1-2):85-94.
2007: Maarit Anttila; Kirsi Voutilainen; Satu Merivalo; Seppo Saarikoski; Veli-Matti Kosma
Prognostic significance of iNOS in epithelial ovarian cancer.
Gynecologic oncology 2007;105(1):97-103.
2007: Sari M Sillanpää; Maarit Anttila; Kirsi Voutilainen; Kirsi Ropponen; Taina Turpeenniemi-Hujanen; Ulla Puistola; Raija Tammi; Markku Tammi; Reijo K Sironen; Seppo Saarikoski; Veli-Matti Kosma
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer.
Gynecologic oncology 2007;104(2):296-303.
2007: Sari M Sillanpää; Maarit Anttila; K Suhonen; Kaisa Mari Hämäläinen; Taina Turpeenniemi-Hujanen; Ulla Puistola; Markku Tammi; Reijo K Sironen; Seppo Saarikoski; Veli-Matti Kosma
Prognostic significance of extracellular matrix metalloproteinase inducer and matrix metalloproteinase 2 in epithelial ovarian cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2007;28(5):280-9.
2006: Pirkko Kouri; Hannele Turunen; Kerttu Tossavainen; Seppo Saarikoski
Pregnant families' discussions on the Net--from virtual connections toward real-life community.
Journal of midwifery & women's health 2006;51(4):279-83.
2006: Kaisa M Randell; Risto Honkanen; Marjo Tuppurainen; Heikki Kröger; Jukka S Jurvelin; Seppo Saarikoski
Fracture risk and bone density of peri- and early postmenopausal women with uterine leiomyomas.
Maturitas 2006;53(3):333-42.
2006: Pirkko Kouri; Hannele Turunen; Kerttu Tossavainen; Seppo Saarikoski
Online discussions mirroring family life during pregnancy.
Informatics in primary care 2006;14(1):41-7.
2006: Kati Pentti; Risto Honkanen; Marjo Tuppurainen; Lorenzo Sandini; Heikki Kröger; Seppo Saarikoski
Hormone replacement therapy and mortality in 52- to 70-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study.
European journal of endocrinology / European Federation of Endocrine Societies 2006;154(1):101-7.
2004: Joonas Sirola; Toni Rikkonen; Heikki Kröger; Risto Honkanen; Marjo Tuppurainen; Olavi Airaksinen; Seppo Saarikoski
Factors related to postmenopausal muscle performance: a cross-sectional population-based study.
European journal of applied physiology 2004;93(1-2):102-7.
2004: Anna-Mari Heikkinen; Leo Niskanen; Jukka A Salmi; Markku Koulu; Ullamari Pesonen; M I J Uusitupa; Marja Komulainen; Marjo Tuppurainen; Heikki Kröger; Jukka S Jurvelin; Seppo Saarikoski
Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women.
Bone 2004;35(3):589-94.
2004: Sari Toivonen; Leea Keski-Nisula; Seppo Saarikoski; Seppo Heinonen
Risk of placental abruption in first-degree relatives of index patients.
Clinical genetics 2004;66(3):244-6.
2004: Sari Toivonen; Seppo Heinonen; Maarit Anttila; Veli-Matti Kosma; Seppo Saarikoski
Obstetric prognosis after placental abruption.
Fetal diagnosis and therapy 2004;19(4):336-41.
2003: Kirsi Voutilainen; Maarit Anttila; Sari M Sillanpää; Raija Tammi; Markku Tammi; Seppo Saarikoski; Veli-Matti Kosma
Versican in epithelial ovarian cancer: relation to hyaluronan, clinicopathologic factors and prognosis.
International journal of cancer. Journal international du cancer 2003;107(3):359-64.
2003: M Juntunen; Leo Niskanen; J Saarelainen; Marjo Tuppurainen; Seppo Saarikoski; Risto Honkanen
Changes in body weight and onset of hypertension in perimenopausal women.
Journal of human hypertension 2003;17(11):775-9.
2003: Joonas Sirola; Heikki Kröger; Risto Honkanen; Jukka S Jurvelin; Lorenzo Sandini; Marjo Tuppurainen; Seppo Saarikoski
Factors affecting bone loss around menopause in women without HRT: a prospective study.
Maturitas 2003;45(3):159-67.
2003: Joonas Sirola; Heikki Kröger; Lorenzo Sandini; Marjo Tuppurainen; Jukka S Jurvelin; Seppo Saarikoski; Risto Honkanen
Interaction of nutritional calcium and HRT in prevention of postmenopausal bone loss: a prospective study.
Calcified tissue international 2003;72(6):659-65.
2003: Joonas Sirola; Heikki Kröger; Risto Honkanen; Lorenzo Sandini; Marjo Tuppurainen; Jukka S Jurvelin; Seppo Saarikoski
Smoking may impair the bone protective effects of nutritional calcium: a population-based approach.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(6):1036-42.
2003: Timo Salmén; Anna-Mari Heikkinen; Anitta Mahonen; Heikki Kröger; Marja Komulainen; Heli Pallonen; Seppo Saarikoski; Risto Honkanen; Pekka H Mäenpää
Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(2):319-24.
2003: Timo Salmen; Anna-Mari Heikkinen; Anitta Mahonen; Heikki Kröger; Marja Komulainen; Heli Pallonen; Seppo Saarikoski; Risto Honkanen; Pekka H Mäenpää
Relation of aromatase gene polymorphism and hormone replacement therapy to serum estradiol levels, bone mineral density, and fracture risk in early postmenopausal women.
Annals of medicine 2003;35(4):282-8.
2003: Joonas Sirola; Heikki Kröger; Risto Honkanen; Lorenzo Sandini; Marjo Tuppurainen; Jukka S Jurvelin; Seppo Saarikoski
Risk factors associated with peri- and postmenopausal bone loss: does HRT prevent weight loss-related bone loss?
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2003;14(1):27-33.
2003: Marjo Tuppurainen; Seppo Saarikoski
Estrogens and aging.
Advances in neurology 2003;91():101-6.
2002: Sari Toivonen; Seppo Heinonen; Maarit Anttila; Veli-Matti Kosma; Seppo Saarikoski
Reproductive risk factors, Doppler findings, and outcome of affected births in placental abruption: a population-based analysis.
American journal of perinatology 2002;19(8):451-60.
2002: Seppo Heinonen; Esko Tyrväinen; Jorma Penttinen; Seppo Saarikoski; Esko Ruokonen
Need for critical care in gynaecology: a population-based analysis.
Critical care (London, England) 2002;6(4):371-5.
2002: Joonas Sirola; J Sirola; Risto Honkanen; Heikki Kröger; Jukka S Jurvelin; Pekka H Mäenpää; Seppo Saarikoski
Relation of statin use and bone loss: a prospective population-based cohort study in early postmenopausal women.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2002;13(7):537-41.
2002: Seppo Heinonen; Seppo Saarikoski
Reproductive risk factors, pregnancy characteristics and obstetric outcome in female doctors.
BJOG : an international journal of obstetrics and gynaecology 2002;109(3):261-4.
2002: Kaisa M Randell; Risto Honkanen; Heikki Kröger; Seppo Saarikoski
Does hormone-replacement therapy prevent fractures in early postmenopausal women?
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2002;17(3):528-33.
2002: Timo Salmén; Anna-Mari Heikkinen; Anitta Mahonen; Heikki Kröger; Marja Komulainen; Seppo Saarikoski; Risto Honkanen; Juhani Partanen; Pekka H Mäenpää
Relation of estrogen receptor-alpha gene polymorphism and hormone replacement therapy to fall risk and muscle strength in early postmenopausal women.
Annals of medicine 2002;34(1):64-72.
2002: A Valtola; R Honkanen; H Kröger; Marjo Tuppurainen; Seppo Saarikoski; E Alhava
Lifestyle and other factors predict ankle fractures in perimenopausal women: a population-based prospective cohort study.
Bone 2002;30(1):238-42.
2001: M L Eloranta; Seppo Heinonen; T Mononen; Seppo Saarikoski
Risk of obstetric cholestasis in sisters of index patients.
Clinical genetics 2001;60(1):42-5.
2001: Kaisa M Randell; R J Honkanen; Marja Komulainen; M T Tuppurainen; H Kröger; Seppo Saarikoski
Hormone replacement therapy and risk of falling in early postmenopausal women - a population-based study.
Clinical endocrinology 2001;54(6):769-74.
2001: Seppo Heinonen; Seppo Saarikoski
Reproductive risk factors of fetal asphyxia at delivery: a population based analysis.
Journal of clinical epidemiology 2001;54(4):407-10.
2000: Timo Salmén; Anna-Mari Heikkinen; Anitta Mahonen; Heikki Kröger; Marja Komulainen; Seppo Saarikoski; Risto Honkanen; Pekka H Mäenpää
The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2000;15(12):2479-86.
2000: Maarit Anttila; Jari K Kellokoski; KI Moisio; P J Mitchell; Seppo Saarikoski; Kari Syrjänen; Veli-Matti Kosma
Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer.
British journal of cancer 2000;82(12):1974-83.
2000: Timo Salmén; Anna-Mari Heikkinen; Anitta Mahonen; Heikki Kröger; Marja Komulainen; Seppo Saarikoski; Risto Honkanen; Pekka H Mäenpää
Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2000;15(2):315-21.
2000: Anna-Mari Heikkinen; Heikki Kröger; Leo Niskanen; Marja Komulainen; Markku Ryynänen; Markku Parviainen; Marjo Tuppurainen; Risto Honkanen; Seppo Saarikoski
Does apolipoprotein E genotype relate to BMD and bone markers in postmenopausal women?
Maturitas 2000;34(1):33-41.
2000: Risto Honkanen; K Honkanen; Heikki Kröger; Esko Alhava; Marjo Tuppurainen; Seppo Saarikoski
Risk factors for perimenopausal distal forearm fracture.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2000;11(3):265-70.
2000: Marja Komulainen; Heikki Kröger; Marjo Tuppurainen; Anna-Mari Heikkinen; Risto Honkanen; Seppo Saarikoski
Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2000;11(3):211-8.
1999: Maarit Anttila; Veli-Matti Kosma; J Hongxiu; Jukka Puolakka; Matti Juhola; Seppo Saarikoski; Kari Syrjänen
p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer.
British journal of cancer 1999;79(11-12):1870-8.
1999: Maarit Anttila; S Syrjänen; Hongxiu Ji; Seppo Saarikoski; Kari Syrjänen
Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR.
Gynecologic oncology 1999;72(3):337-41.
1999: Marja Komulainen; Heikki Kröger; Marjo Tuppurainen; Anna-Mari Heikkinen; Esko Alhava; Risto Honkanen; Jukka S Jurvelin; Seppo Saarikoski
Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial.
The Journal of clinical endocrinology and metabolism 1999;84(2):546-52.
1999: Anna-Mari Heikkinen; Leo Niskanen; Markku Ryynänen; Marja Komulainen; Marjo Tuppurainen; Markku Parviainen; Seppo Saarikoski
Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype?
Arteriosclerosis, thrombosis, and vascular biology 1999;19(2):402-7.
1998: Marja Komulainen; Heikki Kröger; Marjo Tuppurainen; Anna-Mari Heikkinen; Esko Alhava; Risto Honkanen; Seppo Saarikoski
HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial.
Maturitas 1998;31(1):45-54.
1998: Maarit Anttila; Veli-Matti Kosma; Hongxiu Ji; X Wei-Ling; Jukka Puolakka; Matti Juhola; Seppo Saarikoski; Kari Syrjänen
Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2591-600.
1998: Anna-Mari Heikkinen; Leo Niskanen; S Ylä-Herttuala; J Luoma; Marjo Tuppurainen; Marja Komulainen; Seppo Saarikoski
Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL.
Maturitas 1998;29(2):155-61.
1998: Marjo Tuppurainen; Marja Komulainen; Heikki Kröger; Risto Honkanen; Jukka S Jurvelin; E Puntila; Anna-Mari Heikkinen; Esko Alhava; Seppo Saarikoski
Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1998;8(1):32-8.
1998: Risto Honkanen; Marjo Tuppurainen; H Kröger; Esko Alhava; Seppo Saarikoski
Relationships between risk factors and fractures differ by type of fracture: a population-based study of 12,192 perimenopausal women.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1998;8(1):25-31.
1998: Anna-Mari Heikkinen; Markku Parviainen; Marjo Tuppurainen; Leo Niskanen; Marja Komulainen; Seppo Saarikoski
Effects of postmenopausal hormone replacement therapy with and without vitamin D3 on circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D.
Calcified tissue international 1998;62(1):26-30.
1997: Risto Honkanen; H Kröger; Esko Alhava; P Turpeinen; Marjo Tuppurainen; Seppo Saarikoski
Lactose intolerance associated with fractures of weight-bearing bones in Finnish women aged 38-57 years.
Bone 1997;21(6):473-7.
1997: Anna-Mari Heikkinen; Marjo Tuppurainen; Leo Niskanen; Marja Komulainen; I Penttilä; Seppo Saarikoski
Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy.
European journal of endocrinology / European Federation of Endocrine Societies 1997;137(5):495-502.
1997: Leea Keski-Nisula; Pertti Kirkinen; M Ollikainen; Seppo Saarikoski
C-reactive protein in uncomplicated parturients delivered by cesarean section.
Acta obstetricia et gynecologica Scandinavica 1997;76(9):862-7.
1997: Anna-Mari Heikkinen; Markku Parviainen; Leo Niskanen; Marja Komulainen; Marjo Tuppurainen; Heikki Kröger; Seppo Saarikoski
Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
The Journal of clinical endocrinology and metabolism 1997;82(8):2476-82.
1997: Leea Keski-Nisula; Pertti Kirkinen; ML Katila; M Ollikainen; S Suonio; Seppo Saarikoski
Amniotic fluid U. urealyticum colonization: significance for maternal peripartal infections at term.
American journal of perinatology 1997;14(3):151-6.
1997: Leea Keski-Nisula; Pertti Kirkinen; ML Katila; M Ollikainen; Seppo Saarikoski
Cesarean delivery. Microbial colonization in amniotic fluid.
The Journal of reproductive medicine 1997;42(2):91-8.
1997: Leea Keski-Nisula; ML Katila; Pertti Kirkinen; M Ollikainen; Seppo Saarikoski
Amniotic fluid leukocytes and leukocyte esterase activity in parturients delivered by caesarean section.
Scandinavian journal of infectious diseases 1997;29(3):291-6.
1997: Marja Komulainen; Marjo Tuppurainen; Heikki Kröger; Anna-Mari Heikkinen; E Puntila; Esko Alhava; Risto Honkanen; Seppo Saarikoski
Vitamin D and HRT: no benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized placebo-controlled study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1997;7(2):126-32.